OHI
Omega Healthcare Investors, Inc.
Price Chart
Latest Quote
$45.67
+0.59 (+1.31%)
Current Price
| Previous Close | $45.08 |
| Open | $44.61 |
| Day High | $45.71 |
| Day Low | $45.33 |
| Volume | 48,885 |
Stock Information
| Quarterly Dividend / Yield | $2.68 / 5.94% |
| Shares Outstanding | 297.80M |
| Quarterly Dividend Yield | 5.94% |
| Quarterly Dividend | $2.68 |
| Total Debt | $4.45B |
| Cash Equivalents | $26.15M |
| Revenue | $1.23B |
| Net Income | $615.87M |
| Sector | Real Estate |
| Industry | REIT - Healthcare Facilities |
| Market Cap | $14.24B |
| P/E Ratio | 22.06 |
| EPS (TTM) | $2.07 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $18.11B |
| Sales | $1.23B |
| Income | $615.87M |
| Book/sh | $17.43 |
| Cash/sh | $0.09 |
| Employees | 69 |
Financial Ratios
| Quick Ratio | 0.31 |
| Current Ratio | 0.56 |
| Debt/Eq | 81.51 |
| EPS Growth TTM | 38.50% |
Returns & Margins
| ROA | 4.98% |
| ROE | 12.63% |
| Gross Margin | 99.30% |
| Operating Margin | 65.47% |
| Profit Margin | 51.41% |
Ownership
| Insider Ownership | 0.20% |
| Institutional Ownership | 81.79% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 22.45 |
| PEG | 11.99 |
| P/S | 11.58 |
| P/B | 2.62 |
Analyst Data
| Recommendation | buy |
| Target Price | $50.65 |
Technical Indicators
| SMA20 | $45.46 |
| SMA50 | $46.14 |
| SMA200 | $43.67 |
| RSI | 54.94 |
| ATR | 1.1443 |
| Shares Float | 296.79M |
| Short Float | 4.57% |
| Short Ratio | 5.98 |
| Volatility | 0.58 |
| Rel Volume | 0.02 |
Performance History
| Week | +1.02% |
| Month | -5.37% |
| Quarter | +3.32% |
| 6 Months | +5.65% |
| YTD | +5.61% |
| Year | +31.54% |
| 3 Years | +82.23% |
| 5 Years | +83.52% |
| 10 Years | +211.17% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $45.67 | 48,885 |
| 2026-06-22 | $45.10 | 1,931,400 |
| 2026-06-18 | $44.53 | 4,144,700 |
| 2026-06-17 | $44.64 | 2,196,000 |
| 2026-06-16 | $45.50 | 2,724,700 |
| 2026-06-15 | $45.21 | 3,449,700 |
| 2026-06-12 | $45.77 | 1,496,200 |
| 2026-06-11 | $45.28 | 2,483,000 |
| 2026-06-10 | $45.86 | 2,508,300 |
| 2026-06-09 | $45.67 | 3,288,700 |
| 2026-06-08 | $43.80 | 4,628,600 |
| 2026-06-05 | $44.47 | 3,643,900 |
| 2026-06-04 | $43.67 | 2,355,400 |
| 2026-06-03 | $44.05 | 2,128,900 |
| 2026-06-02 | $44.81 | 2,877,300 |
| 2026-06-01 | $45.38 | 2,204,400 |
| 2026-05-29 | $46.76 | 3,052,800 |
| 2026-05-28 | $47.04 | 1,881,600 |
| 2026-05-27 | $47.73 | 2,623,500 |
| 2026-05-26 | $48.34 | 2,105,800 |
About Omega Healthcare Investors, Inc.
Omega Healthcare Investors, Inc. is a Real Estate Investment Trust. The firm is providing financing and capital to the long-term healthcare industry in the United States and the United Kingdom with a focus on skilled nursing and assisted living facilities, including care homes in the United Kingdom. As of September 30, 2025, Omega has a portfolio of investments that includes 1,024 operating facilities located in 42 states, the District of Columbia and the United Kingdom/Jersey (290 facilities) and operated by 88 different operators. Additionally, Omega has investments in several unconsolidated entities that own 19 facilities. As a source of capital to the healthcare industry, Omega continually evaluates the opportunities, trends and challenges affecting the industry. Our goal is to identify long-term investments in quality healthcare properties with outstanding operators that provide the most favorable risk/reward ratio to our investors. Omega Healthcare Investors, Inc. is based in Hunt Valley, United States.
đ° Latest News
Omega Healthcare Investors (OHI) Stock Valuation Check After Recent Mixed Performance And Income Appeal
Simply Wall St. âĸ 2026-06-13T23:12:23Z
PINE or OHI: Which Is the Better Value Stock Right Now?
Zacks âĸ 2026-06-11T15:40:04Z
PINE vs. OHI: Which Stock Is the Better Value Option?
Zacks âĸ 2026-05-26T15:40:03Z
A Look At Omega Healthcare Investors (OHI) Valuation After Its Solid First Quarter Earnings And Dividend Hold
Simply Wall St. âĸ 2026-05-10T17:07:38Z
3 Healthcare Stocks Every Retiree Should Consider
Motley Fool âĸ 2026-05-08T23:35:00Z
SRETâs Monthly Payouts Survive Global Real Estate Stress, Data Shows
24/7 Wall St. âĸ 2026-05-06T14:07:23Z
Omega Healthcare Investors Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-02T05:05:47Z
Top Dividend Stocks To Consider In April 2026
Simply Wall St. âĸ 2026-04-29T17:32:10Z
Omega Healthcare (OHI) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-04-29T15:28:01Z
Omega Healthcare Investors, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-04-29T12:30:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $14,438,000 | $14,561,000 | $15,025,000 | $15,500,000 |
| Cost Of Revenue | $14,438,000 | $14,561,000 | $15,025,000 | $15,500,000 |
| Total Revenue | $1,190,099,000 | $1,051,390,000 | $949,740,000 | $878,244,000 |
| Operating Revenue | $1,177,077,000 | $1,045,117,000 | $946,282,000 | $875,150,000 |
| Expenses | ||||
| Interest Expense | $215,035,000 | $221,716,000 | $235,529,000 | $233,244,000 |
| Total Expenses | $446,158,000 | $391,727,000 | $460,767,000 | $485,967,000 |
| Rent Expense Supplemental | $14,438,000 | $14,561,000 | $15,025,000 | $15,500,000 |
| Other Income Expense | $95,527,000 | $-17,201,000 | $2,189,000 | $277,108,000 |
| Other Non Operating Income Expenses | $50,058,000 | $6,826,000 | $20,297,000 | $-1,997,000 |
| Net Non Operating Interest Income Expense | $-215,035,000 | $-221,716,000 | $-235,529,000 | $-233,244,000 |
| Interest Expense Non Operating | $215,035,000 | $221,716,000 | $235,529,000 | $233,244,000 |
| Operating Expense | $431,720,000 | $377,166,000 | $445,742,000 | $470,467,000 |
| General And Administrative Expense | $104,137,000 | $88,001,000 | $81,504,000 | $69,397,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $590,185,000 | $406,326,000 | $242,180,000 | $426,927,000 |
| Net Interest Income | $-215,035,000 | $-221,716,000 | $-235,529,000 | $-233,244,000 |
| Normalized Income | $545,789,897 | $429,732,946 | $259,844,921 | $150,740,776 |
| Net Income From Continuing And Discontinued Operation | $590,185,000 | $406,326,000 | $242,180,000 | $426,927,000 |
| Average Dilution Earnings | $19,356,000 | $12,060,000 | $7,077,000 | $11,914,000 |
| Net Income Common Stockholders | $572,030,000 | $406,326,000 | $242,180,000 | $426,927,000 |
| Net Income | $590,185,000 | $406,326,000 | $242,180,000 | $426,927,000 |
| Net Income Including Noncontrolling Interests | $609,467,000 | $417,804,000 | $248,796,000 | $438,841,000 |
| Net Income Continuous Operations | $609,467,000 | $417,804,000 | $248,796,000 | $438,841,000 |
| Earnings From Equity Interest Net Of Tax | $-218,000 | $7,916,000 | $-582,000 | $7,261,000 |
| Pretax Income | $624,433,000 | $420,746,000 | $255,633,000 | $436,141,000 |
| Special Income Charges | $45,469,000 | $-24,027,000 | $-18,108,000 | $279,105,000 |
| Operating Income | $743,941,000 | $659,663,000 | $488,973,000 | $392,277,000 |
| Depreciation Amortization Depletion Income Statement | $325,247,000 | $304,648,000 | $319,682,000 | $332,407,000 |
| Depreciation And Amortization In Income Statement | $325,247,000 | $304,648,000 | $319,682,000 | $332,407,000 |
| Gross Profit | $1,175,661,000 | $1,036,829,000 | $934,715,000 | $862,744,000 |
| Per Share | ||||
| Diluted EPS | $1.94 | $1.55 | $1.00 | $1.80 |
| Basic EPS | $1.96 | $1.57 | $1.01 | $1.81 |
| Other | ||||
| Tax Effect Of Unusual Items | $1,073,897 | $-620,054 | $-443,079 | $2,918,776 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,119,246,000 | $971,137,000 | $828,952,000 | $722,687,000 |
| Total Unusual Items | $45,469,000 | $-24,027,000 | $-18,108,000 | $279,105,000 |
| Total Unusual Items Excluding Goodwill | $45,469,000 | $-24,027,000 | $-18,108,000 | $279,105,000 |
| Reconciled Depreciation | $325,247,000 | $304,648,000 | $319,682,000 | $332,407,000 |
| EBITDA (Bullshit earnings) | $1,164,715,000 | $947,110,000 | $810,844,000 | $1,001,792,000 |
| EBIT | $839,468,000 | $642,462,000 | $491,162,000 | $669,385,000 |
| Diluted Average Shares | $304,952,000 | $270,450,000 | $250,451,000 | $244,290,000 |
| Basic Average Shares | $291,648,000 | $258,118,000 | $240,493,000 | $236,256,000 |
| Diluted NI Availto Com Stockholders | $591,386,000 | $418,386,000 | $249,257,000 | $438,841,000 |
| Otherunder Preferred Stock Dividend | $18,155,000 | - | - | - |
| Minority Interests | $-19,282,000 | $-11,478,000 | $-6,616,000 | $-11,914,000 |
| Tax Provision | $14,748,000 | $10,858,000 | $6,255,000 | $4,561,000 |
| Gain On Sale Of Ppe | $67,303,000 | $13,168,000 | $79,668,000 | $359,951,000 |
| Other Special Charges | $-4,995,000 | $1,749,000 | $492,000 | $389,000 |
| Impairment Of Capital Assets | $22,610,000 | $23,831,000 | $91,943,000 | $38,451,000 |
| Restructuring And Mergern Acquisition | $4,219,000 | $11,615,000 | $5,341,000 | $42,006,000 |
| Provision For Doubtful Accounts | $2,336,000 | $-15,483,000 | $44,556,000 | $68,663,000 |
| Selling General And Administration | $104,137,000 | $88,001,000 | $81,504,000 | $69,397,000 |
| Other Gand A | $104,137,000 | $88,001,000 | $81,504,000 | $69,397,000 |
| Write Off | - | - | $0 | $0 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $4,536,673,000 | $3,893,009,000 | $2,930,687,000 | $2,966,217,000 |
| Total Assets | $10,049,059,000 | $9,897,891,000 | $9,117,402,000 | $9,405,163,000 |
| Total Non Current Assets | $7,990,932,000 | $7,261,009,000 | $6,882,518,000 | $7,632,522,000 |
| Other Non Current Assets | $229,408,000 | $189,476,000 | $147,686,000 | $272,960,000 |
| Goodwill And Other Intangible Assets | $644,626,000 | $643,664,000 | $643,897,000 | $643,151,000 |
| Current Assets | $2,058,127,000 | $2,636,882,000 | $2,234,884,000 | $1,772,641,000 |
| Assets Held For Sale Current | $4,000,000 | $56,194,000 | $67,116,000 | $9,456,000 |
| Restricted Cash | $27,539,000 | $30,395,000 | $1,920,000 | $3,541,000 |
| Receivables | $1,999,564,000 | $2,031,953,000 | $1,723,038,000 | $1,462,541,000 |
| Accrued Interest Receivable | $2,363,000 | $1,839,000 | $3,127,000 | $5,696,000 |
| Notes Receivable | $1,228,640,000 | $1,275,039,000 | $974,391,000 | $873,411,000 |
| Loans Receivable | $482,631,000 | $485,533,000 | $513,386,000 | $394,601,000 |
| Accounts Receivable | $285,930,000 | $260,089,000 | $223,418,000 | $180,330,000 |
| Cash Cash Equivalents And Short Term Investments | $27,024,000 | $518,340,000 | $442,810,000 | $297,103,000 |
| Cash And Cash Equivalents | $27,024,000 | $518,340,000 | $442,810,000 | $297,103,000 |
| Other Receivables | - | $9,453,000 | $8,716,000 | $8,503,000 |
| Debt | ||||
| Net Debt | $4,228,987,000 | $4,320,519,000 | $4,624,506,000 | $4,989,731,000 |
| Total Debt | $4,256,011,000 | $4,838,859,000 | $5,067,316,000 | $5,286,834,000 |
| Long Term Debt And Capital Lease Obligation | $4,014,011,000 | $4,838,859,000 | $5,046,919,000 | $5,267,588,000 |
| Long Term Debt | $4,014,011,000 | $4,838,859,000 | $5,046,919,000 | $5,267,588,000 |
| Current Debt And Capital Lease Obligation | $242,000,000 | - | $20,397,000 | $19,246,000 |
| Current Debt | $242,000,000 | - | $20,397,000 | $19,246,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $4,608,560,000 | $5,167,052,000 | $5,355,111,000 | $5,601,881,000 |
| Total Non Current Liabilities Net Minority Interest | $4,014,011,000 | $4,838,859,000 | $5,046,919,000 | $5,267,588,000 |
| Current Liabilities | $594,549,000 | $328,193,000 | $308,192,000 | $334,293,000 |
| Payables And Accrued Expenses | $352,549,000 | $328,193,000 | $287,795,000 | $315,047,000 |
| Non Current Deferred Liabilities | - | - | - | - |
| Non Current Deferred Taxes Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $5,181,299,000 | $4,536,673,000 | $3,574,584,000 | $3,609,368,000 |
| Total Equity Gross Minority Interest | $5,440,499,000 | $4,730,839,000 | $3,762,291,000 | $3,803,282,000 |
| Stockholders Equity | $5,181,299,000 | $4,536,673,000 | $3,574,584,000 | $3,609,368,000 |
| Gains Losses Not Affecting Retained Earnings | $79,037,000 | $22,731,000 | $29,338,000 | $20,325,000 |
| Other Equity Adjustments | $79,037,000 | $22,731,000 | $29,338,000 | $20,325,000 |
| Retained Earnings | $-3,620,324,000 | $-3,429,843,000 | $-3,150,480,000 | $-2,748,585,000 |
| Long Term Equity Investment | $414,127,000 | $88,711,000 | $188,409,000 | $178,920,000 |
| Other | ||||
| Ordinary Shares Number | $295,539,000 | $279,129,000 | $245,282,000 | $234,252,000 |
| Share Issued | $295,539,000 | $279,129,000 | $245,282,000 | $234,252,000 |
| Tangible Book Value | $4,536,673,000 | $3,893,009,000 | $2,930,687,000 | $2,966,217,000 |
| Invested Capital | $9,437,310,000 | $9,375,532,000 | $8,641,900,000 | $8,896,202,000 |
| Working Capital | $1,463,578,000 | $2,308,689,000 | $1,926,692,000 | $1,438,348,000 |
| Total Capitalization | $9,195,310,000 | $9,375,532,000 | $8,621,503,000 | $8,876,956,000 |
| Minority Interest | $259,200,000 | $194,166,000 | $187,707,000 | $193,914,000 |
| Additional Paid In Capital | $8,693,033,000 | $7,915,873,000 | $6,671,198,000 | $6,314,203,000 |
| Capital Stock | $29,553,000 | $27,912,000 | $24,528,000 | $23,425,000 |
| Common Stock | $29,553,000 | $27,912,000 | $24,528,000 | $23,425,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Line Of Credit | $242,000,000 | $0 | $20,397,000 | $19,246,000 |
| Current Accrued Expenses | $352,549,000 | $328,193,000 | $287,795,000 | $315,047,000 |
| Investments And Advances | $414,127,000 | $88,711,000 | $188,409,000 | $178,920,000 |
| Investment Properties | $6,702,771,000 | $6,339,158,000 | $5,902,526,000 | $6,537,491,000 |
| Goodwill | $644,626,000 | $643,664,000 | $643,897,000 | $643,151,000 |
| Investmentsin Joint Venturesat Cost | - | $88,711,000 | $188,409,000 | $178,920,000 |
| Treasury Shares Number | - | - | $0 | - |
| Other Investments | - | - | - | - |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $878,551,000 | $749,430,000 | $617,736,000 | $625,727,000 |
| Operating Activities | ||||
| Operating Cash Flow | $878,551,000 | $749,430,000 | $617,736,000 | $625,727,000 |
| Cash Flow From Continuing Operating Activities | $878,551,000 | $749,430,000 | $617,736,000 | $625,727,000 |
| Operating Gains Losses | $-61,169,000 | $-11,221,000 | $-79,486,000 | $-359,496,000 |
| Investing Activities | ||||
| Investing Cash Flow | $-539,792,000 | $-671,164,000 | $-770,000 | $442,853,000 |
| Cash Flow From Continuing Investing Activities | $-539,792,000 | $-671,164,000 | $-770,000 | $442,853,000 |
| Net Other Investing Changes | $79,854,000 | $-259,319,000 | $-248,677,000 | $-25,071,000 |
| Capital Expenditure | - | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $609,143,000 | $1,235,657,000 | $336,402,000 | $8,112,000 |
| Financing Cash Flow | $-838,256,000 | $26,319,000 | $-473,310,000 | $-789,447,000 |
| Cash Flow From Continuing Financing Activities | $-838,256,000 | $26,319,000 | $-473,310,000 | $-789,447,000 |
| Net Other Financing Charges | $-81,962,000 | $-36,411,000 | $62,074,000 | $-30,510,000 |
| Cash Dividends Paid | $-780,387,000 | $-685,445,000 | $-643,867,000 | $-632,893,000 |
| Common Stock Dividend Paid | $-780,387,000 | $-685,445,000 | $-643,867,000 | $-632,893,000 |
| Net Common Stock Issuance | $609,143,000 | $1,235,657,000 | $336,402,000 | $-134,155,000 |
| Common Stock Issuance | $609,143,000 | $1,235,657,000 | $336,402,000 | $8,112,000 |
| Dividends Received Cfi | $12,913,000 | $1,017,000 | $8,807,000 | $3,328,000 |
| Repurchase Of Capital Stock | - | $0 | $0 | $-142,267,000 |
| Other | ||||
| Repayment Of Debt | $-1,896,758,000 | $-1,145,301,000 | $-734,991,000 | $-589,292,000 |
| Issuance Of Debt | $1,311,708,000 | $657,819,000 | $507,072,000 | $597,403,000 |
| Interest Paid Supplemental Data | $224,046,000 | $230,993,000 | $234,453,000 | $220,748,000 |
| Income Tax Paid Supplemental Data | $4,312,000 | $8,414,000 | $3,615,000 | $5,793,000 |
| End Cash Position | $54,563,000 | $548,735,000 | $444,730,000 | $300,644,000 |
| Beginning Cash Position | $548,735,000 | $444,730,000 | $300,644,000 | $24,411,000 |
| Effect Of Exchange Rate Changes | $5,325,000 | $-580,000 | $430,000 | $-2,900,000 |
| Changes In Cash | $-499,497,000 | $104,585,000 | $143,656,000 | $279,133,000 |
| Net Issuance Payments Of Debt | $-585,050,000 | $-487,482,000 | $-227,919,000 | $8,111,000 |
| Net Long Term Debt Issuance | $-585,050,000 | $-487,482,000 | $-227,919,000 | $8,111,000 |
| Long Term Debt Payments | $-1,896,758,000 | $-1,145,301,000 | $-734,991,000 | $-589,292,000 |
| Long Term Debt Issuance | $1,311,708,000 | $657,819,000 | $507,072,000 | $597,403,000 |
| Net Investment Purchase And Sale | $4,240,000 | $8,429,000 | $11,378,000 | $0 |
| Sale Of Investment | $4,240,000 | $8,429,000 | $11,378,000 | $0 |
| Net Investment Properties Purchase And Sale | $-514,711,000 | $-420,320,000 | $240,072,000 | $464,709,000 |
| Sale Of Investment Properties | $282,776,000 | $95,045,000 | $585,031,000 | $759,047,000 |
| Purchase Of Investment Properties | $-797,487,000 | $-515,365,000 | $-344,959,000 | $-294,338,000 |
| Net Business Purchase And Sale | $-122,088,000 | $-971,000 | $-12,350,000 | $-113,000 |
| Purchase Of Business | $-122,088,000 | $-971,000 | $-12,350,000 | $-113,000 |
| Interest Paid Cfo | $-13,590,000 | $-11,463,000 | $-11,365,000 | $-9,423,000 |
| Change In Working Capital | $-2,948,000 | $32,854,000 | $-15,095,000 | $15,460,000 |
| Change In Other Working Capital | $3,207,000 | $33,760,000 | $3,775,000 | $6,472,000 |
| Change In Other Current Assets | $-9,043,000 | $-61,000 | $-15,210,000 | $5,957,000 |
| Change In Receivables | $2,888,000 | $-845,000 | $-3,660,000 | $3,031,000 |
| Changes In Account Receivables | $2,888,000 | $-845,000 | $-3,660,000 | $3,031,000 |
| Other Non Cash Items | $-75,574,000 | $-32,410,000 | $-36,996,000 | $-51,236,000 |
| Stock Based Compensation | $44,189,000 | $36,696,000 | $35,068,000 | $27,302,000 |
| Provisionand Write Offof Assets | $30,319,000 | $-11,309,000 | $65,189,000 | $193,421,000 |
| Asset Impairment Charge | $22,610,000 | $23,831,000 | $91,943,000 | $38,451,000 |
| Depreciation Amortization Depletion | $325,247,000 | $304,648,000 | $319,682,000 | $332,407,000 |
| Depreciation And Amortization | $325,247,000 | $304,648,000 | $319,682,000 | $332,407,000 |
| Earnings Losses From Equity Investments | $6,134,000 | $1,947,000 | $182,000 | $455,000 |
| Gain Loss On Investment Securities | $-67,303,000 | $-13,168,000 | $-79,668,000 | $-359,951,000 |
| Net Income From Continuing Operations | $609,467,000 | $417,804,000 | $248,796,000 | $438,841,000 |
| Common Stock Payments | - | $0 | $0 | $-142,267,000 |
| Net PPE Purchase And Sale | - | - | $0 | $0 |
| Sale Of PPE | - | - | $0 | $0 |
| Purchase Of Investment | - | - | - | - |
| Purchase Of PPE | - | - | - | - |
Fetched: 2026-06-17